| Followers | 4045 |
| Posts | 152978 |
| Boards Moderated | 3 |
| Alias Born | 08/05/2009 |
Wednesday, November 24, 2021 1:08:08 PM
$30’s bull trap or short trap let’s here some opinions
I think it’s going back down
But it could do the opposite
This market is totally whacked
But
I’d like to get short above $30
I think it’s going back down
But it could do the opposite
This market is totally whacked
But
I’d like to get short above $30
Recent LGVN News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/20/2026 08:13:27 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/20/2026 08:11:44 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/20/2026 08:10:33 PM
- Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities • GlobeNewswire Inc. • 05/20/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 03:43:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:14:12 PM
- Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/13/2026 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:01:43 PM
- Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 05/11/2026 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:17 PM
- Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/05/2026 09:42:35 PM
- Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026 • GlobeNewswire Inc. • 05/05/2026 08:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/17/2026 08:23:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:49:03 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/10/2026 08:01:48 PM
- Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) • GlobeNewswire Inc. • 04/08/2026 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 09:00:15 PM

